MCMary Christie

Mary Christie

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mary Christie has a total of 93 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Immunocytokines with target cell–restricted IL-15 activity for treatment of B cell malignancies

    by Latifa Zekri, Ilona Hagelstein, Melanie Märklin, Boris Klimovich, Mary Christie, Cornelia Lindner, Sofie Kämereit, Nisha Prakash, Stefanie Müller, Sophie Stotz, et al.

    Despite the advances in cancer treatment achieved, for example, by the CD20 antibody rituximab, an urgent medical need remains to optimize the capacity of such antibodies to induce antibody-dependent cellular cytotoxicity (ADCC) that determines therapeutic efficacy. The cytokine IL-15 stimulates proliferation, activation, and cytolytic capacity of NK cells, but broad clinical use is prevented by short half-life, poor accumulation at the tumor site, and severe toxicity due to unspecific immune activation. We here report modified immunocytokines consisting of Fc-optimized CD19 and CD20 antibodies fused to an IL-15 moiety comprising an L45E-E46K double mutation (MIC + format). The E46K mutation abrogated binding to IL-15Rα, thereby enabling substitution of physiological trans-presentation by target binding and thus conditional IL-15Rβγ stimulation, whereas the L45E mutation optimized IL-15Rβγ agonism and producibility. In vitro analysis of NK activation, anti-leukemia reactivity, and toxicity using autologous and allogeneic B cells confirmed target-dependent function of MIC + constructs. Compared with Fc-optimized CD19 and CD20 antibodies, MIC + constructs mediated superior target cell killing and NK cell proliferation. Mouse models using luciferase-expressing human NALM-6 lymphoma cells, patient acute lymphoblastic leukemia (ALL) cells, and murine EL-4 lymphoma cells transduced with human CD19/CD20 as targets and human and murine NK cells as effectors, respectively, confirmed superior and target-dependent anti-leukemic activity. In summary, MIC + constructs combine the benefits of Fc-optimized antibodies and IL-15 cytokine activity and mediate superior NK cell immunity with potentially reduced side effects. They thus constitute a promising new immunotherapeutic approach shown here for B cell malignancies.


  • Open Access

    Molecular basis for GIGYF–TNRC6 complex assembly

    by Meghna Sobti, Benjamin J. Mead, Alastair G. Stewart, Cátia Igreja, Mary Christie

    The GIGYF proteins interact with 4EHP and RNA-associated proteins to elicit transcript-specific translational repression. However, the mechanism by which the GIGYF1/2–4EHP complex is recruited to its target transcripts remain unclear. Here, we report the crystal structures of the GYF domains from GIGYF1 and GIGYF2 in complex with proline-rich sequences from the miRISC-binding proteins TNRC6C and TNRC6A, respectively. The TNRC6 proline-rich motifs bind to a conserved array of aromatic residues on the surface of the GIGYF1/2 GYF domains, thereby bridging 4EHP to Argonaute–miRNA complexes. Our structures also reveal a phenylalanine residue conserved from yeast to human GYF domains that contributes to GIGYF2 thermostability. The molecular details we outline here are likely to be conserved between GIGYF1/2 and other RNA-binding proteins to elicit 4EHP-mediated repression in different biological contexts.


  • Open Access

    Molecular basis for GIGYF-TNRC6 complex assembly in miRNA-mediated translational repression

    by Meghna Sobti, Benjamin J. Mead, Cátia Igreja, Alastair G. Stewart, Mary Christie

    The GIGYF proteins associate with 4EHP and RNA-associated proteins to elicit transcript-specific translational repression. However, the mechanism by which the GIGYF1/2-4EHP complex is recruited to its target transcripts remain unclear. Here we report the crystal structures of the GYF domains from GIGYF1 and GIGYF2 in complex with proline-rich sequences from miRISC-binding proteins TNRC6C and TNRC6A, respectively. The TNRC6 proline-rich motifs bind to a conserved array of aromatic residues on the surface of the GIGYF1/2 GYF domain, bridging 4EHP to Argonaute-miRNA mRNA targets. Our structures also reveal a phenylalanine residue conserved from yeast to human GYF domains that contributes to GIGYF2 thermostability. The molecular details we outline here are likely to be conserved between GIGYF1/2 and other RNA-binding proteins to elicit 4EHP-mediated repression in different biological contexts.

  • Open Access

    Cryo-EM reveals distinct conformations of E. coli ATP synthase on exposure to ATP

    by Meghna Sobti, Robert Ishmukhametov, James C Bouwer, Anita Ayer, Cacang Suarna, Nicola J Smith, Mary Christie, Roland Stocker, Thomas M Duncan, Alastair G Stewart

    ATP synthase produces the majority of cellular energy in most cells. We have previously reported cryo-EM maps of autoinhibited E. coli ATP synthase imaged without addition of nucleotide (Sobti et al. 2016), indicating that the subunit ε engages the α, β and γ subunits to lock the enzyme and prevent functional rotation. Here we present multiple cryo-EM reconstructions of the enzyme frozen after the addition of MgATP to identify the changes that occur when this ε inhibition is removed. The maps generated show that, after exposure to MgATP, E. coli ATP synthase adopts a different conformation with a catalytic subunit changing conformation substantially and the ε C-terminal domain transitioning via an intermediate ‘half-up’ state to a condensed ‘down’ state. This work provides direct evidence for unique conformational states that occur in E. coli ATP synthase when ATP binding prevents the ε C-terminal domain from entering the inhibitory ‘up’ state.


  • Human Antibody Bispecifics through Phage Display Selection

    by Ansha Luthra, David B. Langley, Peter Schofield, Jennifer Jackson, Mahmoud Abdelatti, Romain Rouet, Damien Nevoltris, Ohan Mazigi, Ben Crossett, Mary Christie, et al.

    We developed a repertoire approach to generate human antibody bispecifics. Using phage display selection of antibody heavy chains in the presence of a competitor light chain and providing a cognate light chain with an affinity handle, we identified mutations that prevent heavy/light chain mispairing. The strategy allows for the selection of human antibody chains that autonomously assemble into bispecifics.


  • Open Access

    Structural basis of antigen recognition: crystal structure of duck egg lysozyme

    by David Brent Langley, Ben Crossett, Peter Schofield, Jenny Jackson, Mahdi Zeraati, David Maltby, Mary Christie, Deborah Burnett, Robert Brink, Christopher Goodnow, et al.

    Duck egg lysozyme (DEL) is a widely used model antigen owing to its capacity to bind with differential affinity to anti-chicken egg lysozyme antibodies. However, no structures of DEL have so far been reported, and the situation had been complicated by the presence of multiple isoforms and conflicting reports of primary sequence. Here, the structures of two DEL isoforms from the eggs of the commonly used Pekin duck (Anas platyrhynchos) are reported. Using structural analyses in combination with mass spectrometry, non-ambiguous DEL primary sequences are reported. Furthermore, the structures and sequences determined here enable rationalization of the binding affinity of DEL for well documented landmark anti-lysozyme antibodies.


  • Open Access

    Structural characterisation of TNRC6A nuclear localisation signal in complex with importin-alpha

    by Jessica J. Chaston, Alastair Gordon Stewart, Mary Christie

    The GW182/TNRC6 family of proteins are central scaffolds that link microRNA-associated Argonaute proteins to the cytoplasmic decay machinery for targeted mRNA degradation processes. Although nuclear roles for the GW182/TNRC6 proteins are unknown, recent reports have demonstrated nucleocytoplasmic shuttling activity that utilises the importin-α and importin-β transport receptors for nuclear translocation. Here we describe the structure of mouse importin-α in complex with the TNRC6A nuclear localisation signal peptide. We further show that the interactions observed between TNRC6A and importin-α are conserved between mouse and human complexes. Our results highlight the ability of monopartite cNLS sequences to maximise contacts at the importin-α major binding site, as well as regions outside the main binding cavities.


  • Open Access

    Structural reconstruction of protein ancestry

    by Romain Rouet, David B. Langley, Peter Schofield, Mary Christie, Brendan Roome, Benjamin T. Porebski, Ashley M. Buckle, Ben E. Clifton, Colin J. Jackson, Daniela Stock, et al.

    Significance: The adaptive immune system forms our primary defense against bacteria and viruses. Key players of this system are antigen receptors, dimeric molecules formed by two different types of immunoglobulin domains. It is generally believed that these receptors evolved from an ancestral dimer formed by only a single type of immunoglobulin. Using laboratory evolution, we have recreated such homodimeric receptors and characterized their interactions by X-ray crystallography. Our findings provide molecular insights and support of long-held theories concerning the evolution of the adaptive immune system. They also provide a blueprint for the experimental reconstruction of ancestral proteins in the large number of cases in which evolution has obscured sequence similarities beyond recognition, and which cannot be analyzed using current sequence-based approaches.


  • Cryo-EM analysis of a domain antibody bound rotary ATPase complex

    by Roberta B. Davies, Callum Smits, Andrew S.W. Wong, Daniela Stock, Mary Christie, Sara Sandin, Alastair G. Stewart


  • Structural Biology and Regulation of Protein Import into the Nucleus

    by Mary Christie, Chiung-Wen Chang, Gergely Róna, Kate M. Smith, Alastair G. Stewart, Agnes A.S. Takeda, Marcos R.M. Fontes, Murray Stewart, Beáta G. Vértessy, Jade K. Forwood, et al.